What is DarioHealth's market cap?

DarioHealth (DRIO) has a market capitalization of $75.5M and trades on NASDAQ.

Who are DarioHealth's competitors?

DarioHealth's key competitors include Hims & Hers Health, Inc., Talkspace, Inc., Teladoc Health, Inc., and others. These companies compete in similar markets and product categories.

Who does DarioHealth partner with?

DarioHealth's notable partners include OneStep, Perella Weinberg Partners LP, Eli Lilly, and others.

What subsidiaries does DarioHealth have?

DarioHealth's subsidiaries include Twill, Inc..

Where is DarioHealth headquartered?

DarioHealth is headquartered in United States of America and employs approximately 252 people. It has been publicly traded since 2013.

DarioHealth (DRIO) Stock Fundamentals & Financials

DarioHealth is a vertically integrated health intelligence platform that combines connected hardware, AI-driven analytics, and behavioral coaching to manage chronic conditions.

Market cap

$75.54M+269%

Earnings

Q1 2026 report

May 13, 2026

Revenue$5.6MBeat by $128.0K EPS-$0.81Beat by $0.67

Read the full report

Next report

Aug 11, 2026 (In 2 days)

Revenue estimate$5.9M

EPS estimate-$0.76

Competitors

By market cap

Hims & Hers Health$6.9B-40.6%

Teladoc Health$1.2B-1.7%

Talkspace, Inc.$872.7M+116%

AdaptHealth$806.5M-39.5%

WW International, Inc.$168.8M-95.4%

DarioHealth$75.5M+222%

Definitive Healthcare Corp.$72.3M-82.9%

Dare Bioscience, Inc.$19.9M-0.4%

By revenue growth

Hims & Hers Health+32.8%

Talkspace, Inc.+21.3%

AdaptHealth+1.2%

Teladoc Health-2.1%

Definitive Healthcare Corp.-3.9%

WW International, Inc.-32.8%

By net margin

Talkspace, Inc.0.079%-1.3pp

Hims & Hers Health-0.559%-9.8pp

AdaptHealth-2.42%-5.0pp

Teladoc Health-7.13%+1.0pp

WW International, Inc.-23.21%-221pp

Definitive Healthcare Corp.-71.49%+135pp

Profile

DarioHealth is a vertically integrated health intelligence platform that combines connected hardware, AI-driven analytics, and behavioral coaching to manage chronic conditions. The company leverages proprietary data from FDA-cleared devices to drive sustained user engagement and clinical behavior change across physical and mental health. Its whole-person health model is designed to deliver high clinical efficacy and measurable return on investment for payers and employers.

Competitive position

A vertically integrated leader in digital health consolidation, differentiating through proprietary hardware-generated data and a whole-person health platform.

GeographiesUnited States, Israel, International

Customer segmentsEnterprise, Healthcare Payers, Pharmaceutical Manufacturers, Retail Consumers

Business modelSubscription SaaS, B2B2C, Direct-to-Consumer, Value-based care

SuppliersHardware manufacturing components, Cloud infrastructure providers, AI and machine learning frameworks, Clinical research partners

CustomersSelf-insured employers, Health insurance carriers, Pharmaceutical companies, Individual patients

CountryUnited States of America

Listed2013

Employees252.0

CEOErez Raphael

SectorHealthcare

IndustryMedical - Diagnostics & Research

Websitemydario.com

FilingsSEC EDGAR

FAQ

What is DarioHealth's market cap?: DarioHealth (DRIO) has a market capitalization of $75.5M and trades on NASDAQ.
Who are DarioHealth's competitors?: DarioHealth's key competitors include Hims & Hers Health, Inc., Talkspace, Inc., Teladoc Health, Inc., and others. These companies compete in similar markets and product categories.
Who does DarioHealth partner with?: DarioHealth's notable partners include OneStep, Perella Weinberg Partners LP, Eli Lilly, and others.
What subsidiaries does DarioHealth have?: DarioHealth's subsidiaries include Twill, Inc..
Where is DarioHealth headquartered?: DarioHealth is headquartered in United States of America and employs approximately 252 people. It has been publicly traded since 2013.